Citations (30)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Devin B Lowe, Anamika Bose, Jennifer L Taylor, Hussein Tawbi, Yan Lin, John M Kirkwood & Walter J Storkus. (2014) Dasatinib promotes the expansion of a therapeutically superior T-cell repertoire in response to dendritic cell vaccination against melanoma. OncoImmunology 3:2.
Read now
Read now
Articles from other publishers (29)
Longjia Yan, Yaqing Zuo, Kehui Chen, Ying Xu & Yi Le. (2023) Synthesis and Biological Evaluation of 5-Methylpyrimidine Derivatives as Dual Inhibitors of EGFR and Src for Cancer Treatment. HETEROCYCLES 106:4, pages 742.
Crossref
Crossref
Shannon N. Westin, Anil K. Sood & Robert L. Coleman. 2023. DiSaia and Creasman Clinical Gynecologic Oncology. DiSaia and Creasman Clinical Gynecologic Oncology
464
488.e11
.
Cecilia Villegas, Rebeca Perez, Olov Sterner, Iván González-Chavarría & Cristian Paz. (2021) Curcuma as an adjuvant in colorectal cancer treatment. Life Sciences 286, pages 120043.
Crossref
Crossref
Mingsong Shi, Lun Wang, Penghui Li, Jiang Liu, Lijuan Chen & Dingguo Xu. (2021) Dasatinib–SIK2 Binding Elucidated by Homology Modeling, Molecular Docking, and Dynamics Simulations. ACS Omega 6:16, pages 11025-11038.
Crossref
Crossref
Mohammed A. Alarjah, Mostafa H. Shahin, Firas Al-Azzah, Abdallah A. Alarjah & Ziad H. Omran. (2020) Concomitant analysis of dasatinib and curcuminoids in a pluronic-based nanoparticle formulation using a novel HPLC method. Chromatographia 83:11, pages 1355-1370.
Crossref
Crossref
Jiali Liu, Xiaoliang Jin, Fang Zhou, Hongzhu Chen, Wenjie Wang, Yan Liu, Guangji Wang, Kun Hao & Jingwei Zhang. (2020) Disrupted hepatic pentose phosphate pathway directly participates in and indirectly promotes CYP3A reduction: A new strategy for CYP3A‐mediated drug hepatotoxicity. British Journal of Pharmacology 177:7, pages 1538-1555.
Crossref
Crossref
Raquel Carvalho Montenegro, Alison Howarth, Alessandro Ceroni, Vita Fedele, Batoul Farran, Felipe Pantoja Mesquita, Martin Frejno, Benedict-Tilman Berger, Stephanie Heinzlmeir, Heba Z. Sailem, Roberta Tesch, Daniel Ebner, Stefan Knapp, Rommel Burbano, Bernhard Kuster & Susanne Müller. (2020) Identification of molecular targets for the targeted treatment of gastric cancer using dasatinib. Oncotarget 11:5, pages 535-549.
Crossref
Crossref
Veronica Vella, Roberta Malaguarnera, Maria Luisa Nicolosi, Andrea Morrione & Antonino Belfiore. (2019) Insulin/IGF signaling and discoidin domain receptors: An emerging functional connection. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1866:11, pages 118522.
Crossref
Crossref
Sai Ma, Chen-Chen Lu, Li-Yan Yang, Juan-Juan Wang, Bo-Shi Wang, Hong-Qing Cai, Jia-Jie Hao, Xin Xu, Yan Cai, Yu Zhang & Ming-Rong Wang. (2018) ANXA2 promotes esophageal cancer progression by activating MYC-HIF1A-VEGF axis. Journal of Experimental & Clinical Cancer Research 37:1.
Crossref
Crossref
Madjid Ait Sidhoum, Laurent El Kaïm & Laurence Grimaud. (2018) 4-Aminopyrimidine libraries from the Ugi-Smiles reaction of thiouracil. Tetrahedron 74:38, pages 5222-5231.
Crossref
Crossref
Shannon N. Westin, Anil K. Sood & Robert L. Coleman. 2018. Clinical Gynecologic Oncology. Clinical Gynecologic Oncology
470
492.e10
.
Can Hekim, Mette Ilander, Jun Yan, Erin Michaud, Richard Smykla, Markus Vähä-Koskela, Paula Savola, Siri Tähtinen, Leena Saikko, Akseli Hemminki, Panu E. Kovanen, Kimmo Porkka, Francis Y.F. Lee & Satu Mustjoki. (2017) Dasatinib Changes Immune Cell Profiles Concomitant with Reduced Tumor Growth in Several Murine Solid Tumor Models. Cancer Immunology Research 5:2, pages 157-169.
Crossref
Crossref
Takaya Shiozaki & Shannon N. Westin. 2017. Precision Molecular Pathology of Uterine Cancer. Precision Molecular Pathology of Uterine Cancer
187
223
.
Juanjuan Xiao, Qiuhong Duan, Zhe Wang, Wei Yan, Huimin Sun, Peipei Xue, Xiaoming Fan, Xiaoyu Zeng, Juan Chen, Chen Shao & Feng Zhu. (2016) Phosphorylation of TOPK at Y74, Y272 by Src increases the stability of TOPK and promotes tumorigenesis of colon. Oncotarget 7:17, pages 24483-24494.
Crossref
Crossref
Branka Radic-Sarikas, Uwe Rix, Alexey Stukalov, Manuela Gridling, André C. Müller, Jacques Colinge, Giulio Superti-Furga & Keiryn L. Bennett. (2015) Enhancing cognate target elution efficiency in gel-free chemical proteomics. EuPA Open Proteomics 9, pages 43-53.
Crossref
Crossref
JUAN XIAO, MANMAN XU, TENG HOU, YONGWEN HUANG, CHENLU YANG & JUNDONG LI. (2015) Dasatinib enhances antitumor activity of paclitaxel in ovarian cancer through Src signaling. Molecular Medicine Reports 12:3, pages 3249-3256.
Crossref
Crossref
Yun Bai, Jae-Young Kim, January M. Watters, Bin Fang, Fumi Kinose, Lanxi Song, John M. Koomen, Jamie K. Teer, Kate Fisher, Yian Ann Chen, Uwe Rix & Eric B. Haura. (2014) Adaptive Responses to Dasatinib-Treated Lung Squamous Cell Cancer Cells Harboring DDR2 Mutations. Cancer Research 74:24, pages 7217-7228.
Crossref
Crossref
William Petersen, Jingbo Liu, Liangping Yuan, Hongying Zhang, Matthew Schneiderjan, Yoon-Jae Cho & Tobey J. MacDonald. (2014) Dasatinib suppression of medulloblastoma survival and migration is markedly enhanced by combining treatment with the aurora kinase inhibitor AT9283. Cancer Letters 354:1, pages 68-76.
Crossref
Crossref
Piero Giansanti, Christian Preisinger, Kilian V. M. Huber, Manuela Gridling, Giulio Superti-Furga, Keiryn L. Bennett & Albert J. R. Heck. (2014) Evaluating the Promiscuous Nature of Tyrosine Kinase Inhibitors Assessed in A431 Epidermoid Carcinoma Cells by Both Chemical- and Phosphoproteomics. ACS Chemical Biology 9:7, pages 1490-1498.
Crossref
Crossref
HONG-QUAN DUONG, YONG WEON YI, HYO JIN KANG, INSOO BAE, YOUNG-JOO JANG, SAHNG-JUNE KWAK & YEON-SUN SEONG. (2014) Combination of dasatinib and gemcitabine reduces the ALDH1A1 expression and the proliferation of gemcitabine-resistant pancreatic cancer MIA PaCa-2 cells. International Journal of Oncology 44:6, pages 2132-2138.
Crossref
Crossref
Debra H. Josephs, Danielle S. Fisher, James Spicer & Robert J. Flanagan. (2013) Clinical Pharmacokinetics of Tyrosine Kinase Inhibitors. Therapeutic Drug Monitoring 35:5, pages 562-587.
Crossref
Crossref
Justin Nathaniel Baker, Jennifer A. Windham, Pamela S. Hinds, Jami S. Gattuso, Belinda Mandrell, Poorna Gajjar, Nancy K. West, Teresa Hammarback & Alberto Broniscer. (2013) Bereaved Parents' Intentions and Suggestions about Research Autopsies in Children with Lethal Brain Tumors. The Journal of Pediatrics 163:2, pages 581-586.
Crossref
Crossref
Christine M. Chan, Xia Jing, Laura A. Pike, Qiong Zhou, Dong-Jun Lim, Sharon B. Sams, Gregory S. Lund, Vibha Sharma, Bryan R. Haugen & Rebecca E. Schweppe. (2012) Targeted Inhibition of Src Kinase with Dasatinib Blocks Thyroid Cancer Growth and Metastasis. Clinical Cancer Research 18:13, pages 3580-3591.
Crossref
Crossref
Shannon N. Westin, Anil K. Sood & Robert L. Coleman. 2012. Clinical Gynecologic Oncology. Clinical Gynecologic Oncology
539
560.e6
.
Erica L. Mayer, Jean-Francois Baurain, Joseph Sparano, Lewis Strauss, Mario Campone, Pierre Fumoleau, Hope Rugo, Ahmad Awada, Oumar Sy & Antonio Llombart-Cussac. (2011) A Phase 2 Trial of Dasatinib in Patients with Advanced HER2-Positive and/or Hormone Receptor–Positive Breast Cancer. Clinical Cancer Research 17:21, pages 6897-6904.
Crossref
Crossref
Jyoti Nautiyal, Shailender S Kanwar, Yingjie Yu & Adhip P N Majumdar. (2011) Combination of dasatinib and curcumin eliminates chemo-resistant colon cancer cells. Journal of Molecular Signaling 6, pages 7.
Crossref
Crossref
Wukun Liu, Jinpei Zhou, Fan Qi, Kerstin Bensdorf, Zhiyu Li, Huibin Zhang, Hai Qian, Wenlong Huang, Xueting Cai, Peng Cao, Anja Wellner & Ronald Gust. (2011) Synthesis and Biological Activities of 2-Amino-thiazole-5-carboxylic Acid Phenylamide Derivatives. Archiv der Pharmazie 344:7, pages 451-458.
Crossref
Crossref
Peter S. Hammerman, Martin L. Sos, Alex H. Ramos, Chunxiao Xu, Amit Dutt, Wenjun Zhou, Lear E. Brace, Brittany A. Woods, Wenchu Lin, Jianming Zhang, Xianming Deng, Sang Min Lim, Stefanie Heynck, Martin Peifer, Jeffrey R. Simard, Michael S. Lawrence, Robert C. Onofrio, Helga B. Salvesen, Danila Seidel, Thomas Zander, Johannes M. Heuckmann, Alex Soltermann, Holger Moch, Mirjam Koker, Frauke Leenders, Franziska Gabler, Silvia Querings, Sascha Ansén, Elisabeth Brambilla, Christian Brambilla, Philippe Lorimier, Odd Terje Brustugun, Åslaug Helland, Iver Petersen, Joachim H. Clement, Harry Groen, Wim Timens, Hannie Sietsma, Erich Stoelben, Jürgen Wolf, David G. Beer, Ming Sound Tsao, Megan Hanna, Charles Hatton, Michael J. Eck, Pasi A. Janne, Bruce E. Johnson, Wendy Winckler, Heidi Greulich, Adam J. Bass, Jeonghee Cho, Daniel Rauh, Nathanael S. Gray, Kwok-Kin Wong, Eric B. Haura, Roman K. Thomas & Matthew Meyerson. (2011)
Mutations in the
DDR2
Kinase Gene Identify a Novel Therapeutic Target in Squamous Cell Lung Cancer
. Cancer Discovery 1:1, pages 78-89.
Crossref
Crossref
Wei Fu, Le Ma, Baoky Chu, Xue Wang, Marilyn M. Bui, Jennifer Gemmer, Soner Altiok & W. Jackson Pledger. (2011) The Cyclin-Dependent Kinase Inhibitor SCH 727965 (Dinacliclib) Induces the Apoptosis of Osteosarcoma Cells. Molecular Cancer Therapeutics 10:6, pages 1018-1027.
Crossref
Crossref